About
Retinal Protection Sciences (RPS) is a medical device company dedicated to preventing the most common causes of irreversible vision loss worldwide. Our flagship technology, SAPRA™, is being designed to become the standard of care for both the treatment and prevention of chronic progressive retinopathies—the leading causes of age-related vision loss. Through innovation, compassionate care, and proven results, RPS is committed to safeguarding vision. With decades of expertise and a demonstrated dedication to patient care, we strive to set a new benchmark in preventing blindness from chronic eye diseases. SAPRA™ has not yet been evaluated and approved by the U.S. FDA or regulators for other geographies for commercial sales.
Technologies
Keywords
Company Information
-
Employees 4
